期刊文献+

XpertMTB/RIF在结核病诊断及利福平耐药中的应用 被引量:7

The application of XpertMTB/RIF in TB diagnosis and rifampicin resistance testing
下载PDF
导出
摘要 目的评价XpertMTB/RIF技术在诊断结核病及利福平耐药中的临床应用价值。方法选取196例初诊患者痰标本,分别进行抗酸染色涂片镜检、罗氏固体培养、比例法药敏试验和XpertMTB/RIF检测,对XpertMTB/RIF检测痰标本中结核分枝杆菌(MTB)和利福平耐药性的敏感度和特异度,以及与金标准的一致性进行分析。结果以罗氏培养结果为金标准,XpertMTB/RIF方法检测MTB的敏感度为94.62%(123/130)、特异度为87.88%(58/66),kappa=0.828;以比例法药敏试验结果相比,XpertMTB/RIF方法检测利福平耐药的敏感度73.33%(11/15),特异度为96.30%(104/108),kappa=0.696。结论 XpertMTB/RIF在结核病诊断和利福平耐药检测中敏感度和特异度较高,与传统方法有很好的一致性,且更高效,快捷,安全,更符合成本-效益,值得推广。 Objective To evaluate the accuracy of XpertMTB/RIF assay in the diagnosis of tuberculosis and detection of rifampin resistance.Methods Atotal of 196 initial diagnosis patients were recruited,sputum samples of these patients were tected by smear,solid culture,traditional proportion method drug susceptibility test and XpertMTB/RIF test.The sensitivity and specificity of XpertMTB/RIF method in detecting mycobacterium tuberculosis(MTB)and refampin resistance,and the consistency of this method comparted with the gold standard were andyzed.Results According to the solid culture result,the sensivivity and specificity of XpertMTB/RIF test in detecting tuberculosis were 94.62%(123/130)and 87.88%(58/66),kappa was 0.828;according to conventional drug susceptibility test result,the sensitivity and specificity in detecting rifampin resistance were 73.33%(11/15)and96.30%(104/108)respectively,kappawas 0.696.Conclusion The XpertMTB/RIF test has very high sensitivity and specificity,which also has a good consistency with the traditional method.It is a more efficient,rapid,safer and more cost-effective diagnosis tool for MTB and Rifampicin resistant.
出处 《国际检验医学杂志》 CAS 2016年第10期1368-1370,共3页 International Journal of Laboratory Medicine
关键词 XpertMTB/RIF 结核分枝杆菌 利福平 XpertMTB/RIF mycobacterium tuberculosis rifampin
  • 相关文献

参考文献20

  • 1WHO. Global tuberculosis report 2015[EB/OL]. [2015-07-30]. http ,//www. who. int tb' publications,' global report/en/, htm[.
  • 2WHO. Supplement:Global tuberculosis report 2014. Drug-resist- ant TB Surveillance>.response[EB/OL]. [2015-07-09]. http:// apps. who. int iris bilstream 1065 '137095/1/WHO HQ_ TB_ 2014. 12_eng. pdf? ua-1. html.
  • 3WHO. TB diagnostics and ],qboratory strengthening[EB/OL]. [2015-07-09]. http://wwx who. int,tb/laboratory/en/, html.
  • 4Lawn SD. Nicol MP. Xpert(R) MTB/RIF assay: development, e- valuation and implementation o{ a new rapid molecular diagnostic for tuberculosis and ri{ampicin resistance[J]. Future Microbiol, 2011,6(9) : 1067-1082.
  • 5WHO. Global tuberculosis control 2010 [R]. Geneva: WHO Press,2010.
  • 6Havlir DV, Getahun H, Sanne I, et al. Opportunities and challen- ges for HIV care in overlapping HIV and TB epidemics [J]. JA- MA,2008,300(4) :423-430.
  • 7Dye C,Williams BG. The population dynamics and control of tu- berculosis[J]. Science, 2010,328 (5980) : 856-861.
  • 8Lonnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development [J]. Lancet,2010,375(9728) :1814-1829.
  • 9Boehme CC,Naheta P, Hillemann D,et aL Rapid molecular detec- tion of tuberculosis and ri{ampin resistance[J]. N Engl Med, 2010,363(11) :1005-1015.
  • 10张治国,欧喜超,孙倩,杜春英,高铁杰,赵雁林.利福平耐药实时荧光定量核酸扩增技术检测痰标本中结核分枝杆菌及其耐药性的研究[J].中国防痨杂志,2013,35(1):13-16. 被引量:96

二级参考文献17

  • 1赵雁林,尚美.我国结核病实验室诊断的现状[J].中华检验医学杂志,2007,30(7):725-728. 被引量:57
  • 2Small PM, Pai M. Tuberculosis diagnosis-time for a game change. N Engl J Med, 2010, 363(11):1070-1071.
  • 3Pai M, Kalantri S, Dheda K. New tools and emerging techno- logies for the diagnosis of tuberculosis: Part II. Active tuber- culosis and drug resistance. J Mol Diagn, 2006, 6 (3): 423-432.
  • 4Blakemore R, Story E, Helb D, et al. Evaluation of the ana- lytical performance of the Xpert Mtb/RIF assay. J Clin Micro- biol, 2010, 48 (7): 2495-2501.
  • 5Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010, 363(11):1005-1015.
  • 6Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert Mtb/RIF test for diagnosis of tuberculosis and multidrug re- sistance: a multicentre implementation study. Lancet, 2011,377(9776):1495-1505.
  • 7赵雁林,王黎霞,成诗明,等.分枝杆菌分离培养标准化操作程序及质量保证手册.北京:人民卫生出版社,2013:2.
  • 8中国防痨协会基础专业委员会.结核病诊断实验窒检验规程.北京:中国教育文化出版社,2006.
  • 9赵雁林,王黎霞,成诗明,等.结核分枝杆菌药物敏感性试验准化操作程序及质量保证手册.北京:人民卫生出版社,2013:4.
  • 10Sohn H, Minion J, Albert H, et al. TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther, 2009, 7(6):723-733.

共引文献113

同被引文献67

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部